Pan-immune-inflammation value could be a new marker to differentiate between vascular Beh çet's disease and non-vascular Behçet's disease

CONCLUSIONS: Based on our results, PIV, an easily accessible, cost-effective, and new composite biomarker, has a significant predictive value in VBD.PMID:38497857 | DOI:10.26355/eurrev_202403_35588

Source: Pharmacological Reviews - March 18, 2024 Category: Drugs & Pharmacology Authors: T Ocak N Lerm ı Z Y ılmaz Bozkurt B Yag ız B N Coskun E Dalk ılıc Y Pehl ıvan Source Type: research